Iproniazid (Standard)

• Description:

  Iproniazid (Standard) is the analytical standard of Iproniazid (HY-B0886A) . This product is intended for research and analytical applications. Iproniazid is an orally active, irreversible, non-selective monoamine oxidase (MAO) inhibitor. Iproniazid inhibits MAO activity and enhances Rotenone (HY-B1756) -induced Apoptosis. Iproniazid modulates neurotransmitter levels, affects neuronal function, induces hepatic necrosis, and interferes with the endocrine system. Iproniazid can be used in the research of depression, Parkinson's disease, and hepatotoxicity[1][2][3][4][5][6][7].

• UNSPSC:

  12352100

• Target:

  Apoptosis; Monoamine Oxidase; Reference Standards

• Related Pathways:

  Apoptosis; Neuronal Signaling; Others

• Field of Research:

  Endocrinology; Metabolic Disease; Neurological Disease

• Smiles:

  O=C(C1=CC=NC=C1)NNC(C)C

• Molecular Formula:

  C9H13N3O

• Molecular Weight:

  179.22

• References & Citations:

  [1]Fagervall I, et al. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Biochemical pharmacology 35 (8) : 1381–1387

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference Standards

• CAS Number:

  [54-92-2]